These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
373 related articles for article (PubMed ID: 20497100)
1. Design and Development of Thermoreversible Ophthalmic In Situ Hydrogel of Moxifloxacin HCl. Shastri DH; Prajapati ST; Patel LD Curr Drug Deliv; 2010 Jul; 7(3):238-43. PubMed ID: 20497100 [TBL] [Abstract][Full Text] [Related]
2. Studies on Poloxamer Based Mucoadhesive Insitu Ophthalmic Hydrogel of Moxifloxacin HCL. Shastri DH; Prajapati ST; Patel LD Curr Drug Deliv; 2010 Feb; ():. PubMed ID: 20158483 [TBL] [Abstract][Full Text] [Related]
3. Formulation and evaluation of micro hydrogel of Moxifloxacin hydrochloride. Nanjwade BK; Deshmukh RV; Gaikwad KR; Parikh KA; Manvi FV Eur J Drug Metab Pharmacokinet; 2012 Jun; 37(2):117-23. PubMed ID: 22015966 [TBL] [Abstract][Full Text] [Related]
4. Thermoreversible mucoadhesive ophthalmic in situ hydrogel: Design and optimization using a combination of polymers. Shastri DH; Prajapati ST; Patel LD Acta Pharm; 2010 Sep; 60(3):349-60. PubMed ID: 21134868 [TBL] [Abstract][Full Text] [Related]
5. Thermosensitive and mucoadhesive in situ gel based on poloxamer as new carrier for rectal administration of nimesulide. Yuan Y; Cui Y; Zhang L; Zhu HP; Guo YS; Zhong B; Hu X; Zhang L; Wang XH; Chen L Int J Pharm; 2012 Jul; 430(1-2):114-9. PubMed ID: 22503953 [TBL] [Abstract][Full Text] [Related]
6. Therapeutic Effectiveness in the Treatment of Experimental Bacterial Keratitis with Ion-activated Mucoadhesive Hydrogel. Kesavan K; Kant S; Pandit JK Ocul Immunol Inflamm; 2016 Oct; 24(5):489-92. PubMed ID: 26133969 [TBL] [Abstract][Full Text] [Related]
7. Formulation and evaluation of in situ gelling thermoreversible mucoadhesive gel of fluconazole. Gonjari ID; Hosmani AH; Karmarkar AB; Godage AS; Kadam SB; Dhabale PN Drug Discov Ther; 2009 Feb; 3(1):6-9. PubMed ID: 22495461 [TBL] [Abstract][Full Text] [Related]
8. Sustained ophthalmic delivery of ofloxacin from an ion-activated in situ gelling system. Abraham S; Furtado S; Bharath S; Basavaraj BV; Deveswaran R; Madhavan V Pak J Pharm Sci; 2009 Apr; 22(2):175-9. PubMed ID: 19339228 [TBL] [Abstract][Full Text] [Related]
9. Development and evaluation of a novel in situ gel of sparfloxacin for sustained ocular drug delivery: in vitro and ex vivo characterization. Khan N; Aqil M; Imam SS; Ali A Pharm Dev Technol; 2015; 20(6):662-9. PubMed ID: 24754411 [TBL] [Abstract][Full Text] [Related]
10. Terminalia arjuna gum/alginate in situ gel system with prolonged retention time for ophthalmic drug delivery. Noreen S; Ghumman SA; Batool F; Ijaz B; Basharat M; Noureen S; Kausar T; Iqbal S Int J Biol Macromol; 2020 Jun; 152():1056-1067. PubMed ID: 31751751 [TBL] [Abstract][Full Text] [Related]
11. Thermoreversible in situ gelling poloxamer-based systems with chitosan nanocomplexes for prolonged subcutaneous delivery of heparin: design and in vitro evaluation. Radivojša M; Grabnar I; Ahlin Grabnar P Eur J Pharm Sci; 2013 Sep; 50(1):93-101. PubMed ID: 23524253 [TBL] [Abstract][Full Text] [Related]
12. Preparation and evaluation of nanoparticles loaded ophthalmic in situ gel. Kesarla R; Tank T; Vora PA; Shah T; Parmar S; Omri A Drug Deliv; 2016 Sep; 23(7):2363-2370. PubMed ID: 25579467 [TBL] [Abstract][Full Text] [Related]
13. Comparison of ion-activated in situ gelling systems for ocular drug delivery. Part 1: physicochemical characterisation and in vitro release. Rupenthal ID; Green CR; Alany RG Int J Pharm; 2011 Jun; 411(1-2):69-77. PubMed ID: 21453762 [TBL] [Abstract][Full Text] [Related]
14. Influence of additives on a thermosensitive hydrogel for buccal delivery of salbutamol: relation between micellization, gelation, mechanic and release properties. Zeng N; Dumortier G; Maury M; Mignet N; Boudy V Int J Pharm; 2014 Jun; 467(1-2):70-83. PubMed ID: 24699353 [TBL] [Abstract][Full Text] [Related]
15. Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept. Patel N; Thakkar V; Metalia V; Baldaniya L; Gandhi T; Gohel M Drug Dev Ind Pharm; 2016 Sep; 42(9):1406-23. PubMed ID: 26716613 [TBL] [Abstract][Full Text] [Related]
16. A novel poloxamers/hyaluronic acid in situ forming hydrogel for drug delivery: rheological, mucoadhesive and in vitro release properties. Mayol L; Quaglia F; Borzacchiello A; Ambrosio L; La Rotonda MI Eur J Pharm Biopharm; 2008 Sep; 70(1):199-206. PubMed ID: 18644705 [TBL] [Abstract][Full Text] [Related]
17. Investigation on solution-to-gel characteristic of thermosensitive and mucoadhesive biopolymers for the development of moxifloxacin-loaded sustained release periodontal in situ gels. Sheshala R; Quah SY; Tan GC; Meka VS; Jnanendrappa N; Sahu PS Drug Deliv Transl Res; 2019 Apr; 9(2):434-443. PubMed ID: 29392681 [TBL] [Abstract][Full Text] [Related]
18. Ion-activated in situ gelling systems for sustained ophthalmic delivery of ciprofloxacin hydrochloride. Balasubramaniam J; Pandit JK Drug Deliv; 2003; 10(3):185-91. PubMed ID: 12944139 [TBL] [Abstract][Full Text] [Related]
19. Development of a poloxamer analogs/carbopol-based in situ gelling and mucoadhesive ophthalmic delivery system for puerarin. Qi H; Chen W; Huang C; Li L; Chen C; Li W; Wu C Int J Pharm; 2007 Jun; 337(1-2):178-87. PubMed ID: 17254725 [TBL] [Abstract][Full Text] [Related]
20. Preparation of levofloxacin loaded Jain P; Jaiswal CP; Mirza MA; Anwer MK; Iqbal Z Drug Dev Ind Pharm; 2020 Jan; 46(1):50-56. PubMed ID: 31818154 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]